| Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour (NCT03593226) | Agalimmune Ltd. | 2018-11-30 |
| FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients (NCT03721653) | Gruppo Oncologico del Nord-Ovest | 2018-11-30 |
| Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets (NCT03739632) | Zhejiang Huahai Pharmaceutical Co., Ltd. | 2018-11-30 |
| Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients (NCT03651557) | GNT Pharma | 2018-11-29 |
| Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer (NCT03572400) | Do-Youn Oh | 2018-11-29 |
| Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection (NCT03656510) | Janssen Research & Development, LLC | 2018-11-29 |
| Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (NCT04054362) | Barts & The London NHS Trust | 2018-11-29 |
| A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) (NCT03744676) | Juno Therapeutics, a Subsidiary of Celgene | 2018-11-29 |
| Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS) (NCT04572997) | Kristian Reich | 2018-11-29 |
| Daily Liraglutide for Nicotine Dependence (NCT03712098) | Rebecca Ashare | 2018-11-29 |
| Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma (NCT03623373) | Washington University School of Medicine | 2018-11-29 |
| Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis (NCT03187626) | Assistance Publique - Hôpitaux de Paris | 2018-11-29 |
| Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer (NCT03600701) | National Cancer Institute (NCI) | 2018-11-29 |
| Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (NCT03614923) | AnaptysBio, Inc. | 2018-11-29 |
| A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes. (NCT03751657) | Novo Nordisk A/S | 2018-11-29 |
| The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy (NCT03627130) | Barts & The London NHS Trust | 2018-11-29 |
| A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia (NCT03485053) | MegaPro Biomedical Co. Ltd. | 2018-11-29 |
| Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue (NCT03747757) | M.D. Anderson Cancer Center | 2018-11-29 |
| Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2 (NCT03758950) | Jeffrey Glassberg | 2018-11-29 |
| Sym004 Versus Futuximab or Modotuximab in Patients With mCRC (NCT03549338) | Symphogen A/S | 2018-11-29 |
| A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma (NCT03331731) | Peter MacCallum Cancer Centre, Australia | 2018-11-29 |
| Compassionate Use Study of Tenalisib (RP6530) (NCT03711604) | Rhizen Pharmaceuticals SA | 2018-11-28 |
| Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients (NCT03663335) | Novartis Pharmaceuticals | 2018-11-28 |
| MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin (NCT03778619) | GC Cell Corporation | 2018-11-28 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) (NCT02905578) | University of Iowa | 2018-11-28 |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma (NCT03712202) | City of Hope Medical Center | 2018-11-28 |
| The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread (NCT03659136) | Boehringer Ingelheim | 2018-11-28 |
| Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia (NCT03573024) | University of Colorado, Denver | 2018-11-28 |
| Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis (NCT03452540) | Afimmune | 2018-11-28 |
| Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema (NCT03683719) | LEO Pharma | 2018-11-28 |
| Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma (NCT03713372) | Sinocelltech Ltd. | 2018-11-28 |
| A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer (NCT03703466) | Eli Lilly and Company | 2018-11-28 |
| 18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma (NCT03732352) | Jonsson Comprehensive Cancer Center | 2018-11-28 |
| CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. (NCT03693833) | Aalborg University Hospital | 2018-11-28 |
| Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (NCT03727022) | Biosplice Therapeutics, Inc. | 2018-11-28 |
| Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections (NCT03812900) | A. Vogel AG | 2018-11-27 |
| An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer (NCT03690141) | Effector Therapeutics | 2018-11-27 |
| Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (NCT03506997) | Institute of Cancer Research, United Kingdom | 2018-11-27 |
| Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma (NCT03521830) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-11-27 |
| A Study of Intravenous Perampanel in Japanese Participants With Epilepsy (NCT03754582) | Eisai Co., Ltd. | 2018-11-27 |
| Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer (NCT03747042) | University of Texas Southwestern Medical Center | 2018-11-27 |
| A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease (NCT03745287) | Vertex Pharmaceuticals Incorporated | 2018-11-27 |
| Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer (NCT03637816) | M.D. Anderson Cancer Center | 2018-11-27 |
| Preventing Asthma in High Risk Kids (NCT02570984) | Boston Children's Hospital | 2018-11-27 |
| Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma (NCT03646617) | Abramson Cancer Center at Penn Medicine | 2018-11-27 |
| BOL-DP-o-04 in Patients With Low Back Pain and Sciatica (NCT04145310) | Breath of Life International Pharma Ltd | 2018-11-27 |
| A DDI Study of FDL169 and FDL176 in Healthy Subjects (NCT03756922) | Flatley Discovery Lab LLC | 2018-11-27 |
| Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients (NCT03758014) | Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd | 2018-11-27 |
| SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand) (NCT04198883) | CellProthera | 2018-11-27 |
| Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery (NCT03579602) | Blaze Bioscience Inc. | 2018-11-26 |
| Neuroimaging Study (NCT03618186) | Mayo Clinic | 2018-11-26 |
| Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT03739619) | Emory University | 2018-11-26 |
| An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) (NCT03699449) | Yonsei University | 2018-11-26 |
| Brexpiprazole in Borderline Personality Disorder (NCT03418675) | University of Chicago | 2018-11-26 |
| A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer (NCT03706365) | Eli Lilly and Company | 2018-11-26 |
| Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines (NCT03736928) | Galderma R&D | 2018-11-26 |
| A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects (NCT03715829) | Pfizer | 2018-11-26 |
| Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex (NCT03715478) | Canadian Myeloma Research Group | 2018-11-26 |
| Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment (NCT03637400) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2018-11-26 |
| Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease (NCT03402503) | IntelGenx Corp. | 2018-11-26 |
| A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) (NCT03656744) | HighTide Biopharma Pty Ltd | 2018-11-26 |
| PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol (NCT03617172) | Vanderbilt University Medical Center | 2018-11-26 |
| GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors (NCT03693612) | GlaxoSmithKline | 2018-11-26 |
| Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer (NCT03579784) | Do-Youn Oh | 2018-11-26 |
| Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL) (NCT03711578) | Rhizen Pharmaceuticals SA | 2018-11-25 |
| DWELL: Design For Wellness - An Online Intervention To Create Healthier Home Environments (NCT03736525) | Laura J. Rosen | 2018-11-25 |
| Efficacy and Safety of Balloon Guide Catheter in Mechanical Thrombectomy Patients (NCT03754738) | Capital Medical University | 2018-11-25 |
| Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients (NCT03755193) | Shinshu University | 2018-11-24 |
| Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (NCT03536559) | Clene Nanomedicine | 2018-11-23 |
| Obinutuzumab in Marginal Zone Lymphoma (NCT03322865) | Christian Buske | 2018-11-23 |
| Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC (NCT04664972) | Henan Cancer Hospital | 2018-11-23 |
| Synergism of Immunomodulation and Tumor Ablation (NCT03101475) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-11-23 |
| A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy (NCT03754764) | Chinese PLA General Hospital | 2018-11-23 |
| Effect of Dapagliflozin on IAH in T1DM (NCT03556033) | Radboud University Medical Center | 2018-11-23 |
| Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. (NCT03578367) | Novartis Pharmaceuticals | 2018-11-22 |
| A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma (NCT03711279) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-22 |
| Safety and Tolerability of Oral CM082 in Patients With wAMD (NCT03710863) | AnewPharma | 2018-11-22 |
| A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) (NCT03821610) | University of Birmingham | 2018-11-22 |
| OH2 Injection in Solid Tumors (NCT04386967) | Binhui Biopharmaceutical Co., Ltd. | 2018-11-22 |
| A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC) (NCT04172571) | Akeso | 2018-11-22 |
| Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy (NCT03749642) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2018-11-22 |
| The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma (NCT03407495) | MegaPro Biomedical Co. Ltd. | 2018-11-22 |
| VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma (NCT03750071) | Vaximm GmbH | 2018-11-21 |
| Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis (NCT03717896) | Beth Israel Deaconess Medical Center | 2018-11-21 |
| (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (NCT03580655) | Blueprint Medicines Corporation | 2018-11-21 |
| Examination of Efficacy and Safety of Baricitinib in RA Patients (NCT03755466) | Shinshu University | 2018-11-21 |
| Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy (NCT03811379) | Sun Yat-sen University | 2018-11-21 |
| Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer (NCT03344211) | University of Southern California | 2018-11-21 |
| Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care. (NCT03780894) | Banc de Sang i Teixits | 2018-11-21 |
| Investigational Therapeutics for the Treatment of People With Ebola Virus Disease (NCT03719586) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-11-21 |
| A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia (NCT03538041) | Incyte Corporation | 2018-11-21 |
| MGC018 With or Without MGA012 in Advanced Solid Tumors (NCT03729596) | MacroGenics | 2018-11-21 |
| Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs (NCT04559295) | Stem Cures | 2018-11-21 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
| A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC (NCT03741712) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-20 |
| Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella (NCT03148990) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2018-11-20 |
| Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients. (NCT03735966) | Henan Cancer Hospital | 2018-11-20 |
| Safety, Tolerability and Effects of Mannitol in Parkinson's Disease (NCT03823638) | Hadassah Medical Organization | 2018-11-20 |
| Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative (NCT03765775) | First Hospital of Shijiazhuang City | 2018-11-20 |
| A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (NCT03691051) | Henan Cancer Hospital | 2018-11-20 |